Government Decree No. 463 / 2013 Coll.
Government Regulation on substance lists
Valid
Regulation
Effective from 01.01.2014
463
GOVERNMENT REGULATION
of 18 December 2013
on substance lists
The Government orders pursuant to § 44c (1) of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll.:
This Regulation lays down:
(a) in Annex 1 to this Regulation, the list:
1. narcotic drugs included in List I under the Single Convention on Narcotic Drugs (1); and
2. other narcotic substances with which, because of the extent of their abuse or because they are directly or indirectly endangering health, it is necessary to allow treatment only on the basis of the authorisation for treatment, or for this reason it is necessary to ensure that medicinal products containing these substances are issued in a pharmacy only for a prescription or a request marked with a blue stripe coming from the lower left corner to the upper right corner,
("List No 1 of Narcotic Drugs'),
(b) in Annex 2 to this Regulation, the list:
1. Narcotic substances included in List II under the Single Convention on Narcotic Substances; and
2. other narcotic substances which, by reason of the extent of their abuse or because they are directly or indirectly endangering health, need to be ensured that medicinal products containing such narcotic substances are issued in a prescription or requisition shop without a blue stripe;
(hereinafter referred to as "List No 2 of Narcotic Drugs'),
(c) in Annex 3 to this Regulation, the list:
1. narcotic drugs included in List IV under the Single Convention on Narcotic Drugs; and
2. other narcotic substances for which, by reason of their extent of abuse or because they are directly or indirectly endangering health, it is necessary to ensure that substances and preparations containing these substances are used only for limited research, scientific and very limited therapeutic purposes as defined in the authorisation for treatment,
(hereinafter referred to as "List No 3 of Narcotic Drugs'),
(d) in Annex 4 to this Regulation, the list:
1. psychotropic substances included in List I under the Convention on Psychotropic Substances (2); and
2. other psychotropic substances for which, because of their extent of abuse or because they are directly or indirectly endangering health, it is necessary to ensure that substances and preparations containing these psychotropic substances are used only for limited research, scientific and very limited therapeutic purposes as defined in the authorisation for treatment,
("List No 4 of Psychotropic Substances'),
(e) in Annex 5 to this Regulation, the list:
1. psychotropic substances included in List II under the Convention on Psychotropic Substances; and
2. other psychotropic substances with which, because of the extent of their abuse or because they are directly or indirectly endangering health, it is necessary to allow treatment only on the basis of the authorisation for treatment, or for this reason it is necessary to ensure that medicinal products containing these psychotropic substances are issued in a pharmacy only for a prescription or a request marked with a blue stripe pointing from the lower left corner to the upper right corner,
("List No 5 of psychotropic substances'),
(f) in Annex 6 to this Regulation, the list of psychotropic substances included in List III under the Convention on Psychotropic Substances;
("List No 6 of psychotropic substances'),
(g) in Annex 7 to this Regulation, the list:
1. psychotropic substances included in List IV under the Convention on Psychotropic Substances; and
2. other psychotropic substances for which, because of their extent of abuse or because they are directly or indirectly endangering health, it is necessary to ensure that medicinal products containing these substances are issued in a prescription or requisition pharmacy without a blue stripe;
("List No 7 of psychotropic substances'), and
(h) in Annex 8 to this Regulation, the list of preparations included in List III under the Single Convention on Narcotic Drugs;
("List No 8 of selected products').
(1) This Regulation was notified in accordance with Directive 98 / 34 / EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations and of rules on information society services, as amended.
(2) This Regulation implements the relevant European Union provisions on addictive substances (3).
This Regulation shall take effect on 1 January 2014.
Prime Minister:
Rusnok v. r.
Minister for Health:
Holcate v. r.
Příloha č. 1
Annex No 1 to Government Regulation No 463 / 2013 Coll.
List No 1 of narcotic drugs
| Mezinárodní nechráněný název (INN) v českém jazyce | Chemický název podle IUPAC | Poznámka |
|---|---|---|
| Acetorfin | (5R,6R,7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy-6,14-ethenomorfinan-3-yl-acetát | |
| Acetyl-alfa-methylfentanyl | (RS)-N-[1-(2-fenyl-2-methylethyl)-4-piperidyl]acetanilid | |
| Acetylmethadol | (3RS)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfacetylmethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Alfamethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Alfa-methylfentanyl | N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid | |
| Alfa-methylthiofentanyl | N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Alfaprodin | (3RS,4SR)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát | |
| Alfentanil | N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-fenylpropanamid | |
| Allylprodin | 3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Anileridin | ethyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát | |
| Benzethidin | ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát | |
| Benzylmorfin | 3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6α-ol | |
| Betacetylmethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Beta-hydroxyfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]piperidin-4-yl}propananilid | |
| Beta-hydroxymethylfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]-3-methylpiperidin-4-yl}propananilid | |
| Betameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Betamethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Betaprodin | (3RS,4RS)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát | |
| Bezitramid | 2,2-difenyl-4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidino]butannitril | |
| Dextromoramid | 1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin | |
| Diampromid | N-[2-(N-fenethyl-N-methylamino)propyl]propananilid | |
| Diethylthiambuten | 3-(diethylamino)-1,1-di(2-thienyl)but-1-en | |
| Difenoxin | 1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylová kyselina | |
| Difenoxylát | ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát | |
| Dihydroetorfin | (5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethanomorfinan-3-ol | |
| Dihydromorfin | 4,5α-epoxy-17-methylmorfinan-3,6α-diol | |
| Dimenoxadol | [2-(dimethylamino)ethyl]-2-ethoxy-2,2-difenyl-acetát | |
| Dimefeptanol | 6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Dimethylthiambuten | N,N,1-trimethyl-3,3-di(2-thienyl)allylamin | |
| Dioxafetyl-butyrát | ethyl-2,2-difenyl-4-morfolinobutanoát | Dioxafetylbutyrát |
| Dipipanon | (6RS)-4,4-difenyl-6-piperidinoheptan-3-on | |
| Drotebanol | (6R)-3,4-dimethoxy-17-methylmorfínan-6β,14-diol | |
| Ekgonin | kyselina (1R,2R,3S,5S)3-hydroxy-8-methyl-8-azabicyklo[3.2.1]oktan-2-karboxylová, její estery a deriváty, z kterých je možno získat ekgonin a kokain | |
| Ethylmethylthiambuten | N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin | |
| Etonitazen | 1-[2-(diethylamino)ethyl]-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol | |
| Etoxeridin | ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát | |
| Extrakt z | ||
| Fenadoxon | 4,4-difenyl-6-morfolinoheptan-3-on | |
| Fenampromid | N-(1-methyl-2-piperidinoethyl)propananilid | |
| Fenazocin | (2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | |
| Fenomorfan | 17-fenethylmorfinan-3-ol | |
| Fenoperidin | ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát | |
| Fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid | |
| Furethidin | ethyl-4-fenyl-1-[2-(furfuryloxy)ethyl]piperidin-4-karboxylát | |
| Hydrokodon | 4,5α-epoxy-3-methoxy-17-methylmorfinan-6-on | |
| Hydromorfinol | 4,5α-epoxy-17-methylmorfinan-3,6α,14-triol | |
| Hydromorfon | 4,5α-epoxy-3-hydroxy-17-methylmorfinan-6-on | |
| Hydroxypethidin | ethyl-4-(3-hydroxyfenyl)-1-methylpiperidin-4-karboxylát | |
| Isomethadon | 6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on | |
| Karfentanil | methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát | |
| Klonitazen | 2-(4-chlorbenzyl)-1-[2-(diethylamino)ethyl]-5-nitro-1H-benzimidazol | |
| Kodoxim | kyselina 2-{[N-(4,5α-epoxy-3-methoxy-17-methylmorfinan-6-yliden)amino]oxy}octová | |
| Koka - list | Kokový list | |
| Kokain | (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyklo[3.2.1]oktan-2-karboxylát | |
| Koncentrát z | Poloprodukt k výrobě alkaloidů získaný technologickou úpravou | |
| S výjimkou látky | ||
| Levofenacylmorfan | 1-fenyl-2-[9R,13R,14R)3-hydroxymorfinan-17-yl]ethan-1-on | |
| Levomethorfan | (9R,13R,14R)-3-methoxy-17-methylmorfinan | Stereoizomerní dextromethorfan [(+)-3-methoxy-17-methylmorfinan] je vyňat ze seznamu omamných látek uvedených v této příloze |
| Levomoramid | (3R)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on | |
| Levorfanol | (9R,13R,14R)-17-methylmorfinan-3-ol | Stereoizomerní dextrorfanol [(+)-3-hydroxy-17-methylmorfinan] je vyňat ze seznamu omamných látek uvedených v této příloze |
| Metazocin | (2R,6R,11R)-3,6,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-dimethano-3-benzazocin-8-ol | |
| Methadon | (6RS)-6-(dimethylamino)-4,4-difenylheptan-3-on | |
| Methadon, meziprodukt | 4-(dimethylamino)-2,2-difenylpentannitril | |
| Methyldesorfin | 4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol | |
| Methyldihydromorfín | 4,5-epoxy-6,17-dimethylmorfinan-3,6-diol | |
| Metopon | 4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on | |
| Moramid, meziprodukt | 2,2-difenyl-3-methyl-4-morfolinobutanová kyselina | |
| Methylfentanyl | N-(1-fenethyl-3-methylpiperidin-4-yl)propananilid | 3-Methylfentanyl |
| Methylthiofentanyl | N-{(3RS)-3-methyl-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | 3-methylthiofentanyl |
| Meziprodukt | základně zpracovaná | |
| Morferidin | ethyl-4-fenyl-1-(2-morfolinoethyl)piperidin-4-karboxylát | |
| Morfin | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diol | |
| Morfin methobromid | 4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid | a jiné deriváty morfinu se čtyřvazným dusíkem včetně derivátů morfin-N-oxidu (i kodein-N-oxidu) |
| Morfin-N-oxid | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diol-17-oxid | |
| Desmethylprodin | 4-fenyl-1-methylpiperidin-4-yl-propanoát | MPPP |
| Myrofin | 3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6-yl-tetradekanoát | |
| Nikomorfin | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diyl-dinikotinát | |
| Noracymethadol | 4,4-difenyl-6-(methylamino)heptan-3-yl-acetát | |
| Norlevorfanol | (9R,13R,14R)-morfinan-3-ol | |
| Normethadon | 6-(dimethylamino)-4,4-difenylhexan-3-on | |
| Normorfin | 4,5α-epoxymorfin-7-en-3,6α-diol | |
| Norpipanon | 4,4-difenyl-6-piperidinohexan-3-on | |
| Opium | Kromě homeopaticky vyrobených přípravků, jejichž stupeň ředění je vyšší než D4 nebo CH2 | |
| Oripavin | 4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol | |
| Oxykodon | (5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on | |
| Oxymorfon | (5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on | |
| Parafluorfentanyl | N-(1-fenethylpiperidin-4-yl)-4'-fluorpropananilid | |
| Pheneridin | ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát | PEPAP |
| Pethidin | ethyl-4-fenyl-1-methylpiperidin-4-karboxylát | |
| Pethidin, meziprodukt A | 4-fenyl-1-methylpiperidin-4-karbonitril | |
| Pethidin, meziprodukt B | ethyl-4-fenylpiperidin-4-karboxylát | |
| Pethidin, meziprodukt C | kyselina 4-fenyl-1-methylpiperidin-4-karboxylová | |
| Piminodin | ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát | |
| Piritramid | 1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin | |
| Proheptazin | 4-fenyl-1,3-dimethylazepan-4-yl-propanoát | |
| Properidin | isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát | |
| Racemethorfan | (9RS,13RS,14RS)-3-methoxy-17-methylmorfinan | |
| Racemoramid | (3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on | |
| Racemorfan | (9RS,13RS,14RS)-17-methylmorfinan-3-ol | |
| Remifentanil | methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát | |
| Sufentanil | N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Tapentadol | 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol | |
| Thebain | 4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien | |
| Thebakon | (5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát | |
| Thiafentanil | methyl 4-(N-(2-methoxyacetyl)anilin)-1-(2-thiofen-2-ylethyl)piperidin-4-karboxylát | A-3080, Thianil |
| Thiofentanyl | N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Tilidin | ethyl-(1RS,2RS)-2-(dimethylamino)-1-fenylcyklohex-3-en-1-karboxylát | |
| Trimeperidin | (RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Including the isomers of the narcotic substances listed in this list, the esters and ethers of the narcotic substances listed therein and the salts of the narcotic substances listed therein, including salts of isomers, esters and ethers in all cases where such salts may exist.
Příloha č. 2
Annex No 2 to Government Regulation No 463 / 2013 Coll.
List No 2 of narcotic drugs
| Mezinárodní nechráněný název (INN) v českém jazyce | Chemický název podle IUPAC | Poznámka |
|---|---|---|
| Acetyldihydrokodein | 4,5α-epoxy-3-methoxy-17-methylmorfinan-6α-yl-acetát | |
| Dextropropoxyfen | (1S,2R)-1-benzyl-3-(dimethylamino)-1-fenyl-2-methylpropyl-propanoát | |
| Dihydrokodein | 4,5α-epoxy-3-methoxy-17-methylmorfinan-6α-ol | |
| Ethylmorfin | 4,5α-epoxy-3-ethoxy-17-methylmorfin-7-en-6α-ol | |
| Folkodin | 4,5α-epoxy-17-methyl-3-(2-morfolinoethoxy)morfin-7-en-6α-ol | |
| Kodein | 4,5α-epoxy-3-methoxy-17-methylmorfin-7-en-6α-ol | |
| Nikodikodin | 4,5α-epoxy-3-methoxy-17-methylmorfinan-6α-yl-nikotinát | |
| Nikokodin | 4,5α-epoxy-3-methoxy-17-methylmorfin-7-en-6-yl-nikotinát | |
| Norkodein | 4,5α-epoxy-3-methoxymorfin-7-en-6α-ol | |
| Propiram | N-[(1RS)-1-methyl-2-piperidinoethyl]-N-(2-pyridyl)propanamid |
Including the isomers of the narcotic substances listed in this list, the salts of the narcotic substances listed in that list, including the salts of the isomers of the substances listed in that list in all cases where such salts may exist.
Příloha č. 3
Annex No 3
List No 3 Narcotics
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Acetoxynitazen | [4-[[1-[2-(diethylamino)ethyl]-5-nitrobenzimidazol-2-yl] methyl]fenyl] acetát | ||
| Acetylbenzylfentanyl | benzylacetylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid | NSC 73750 |
| Acetylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid | ||
| Acryloylfentanyl | Acrylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid | |
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | ||
| AP-237 | bucinnazin; 1-N-butyryl-4-cinnamylpiperazine; | 1-[4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| AP-238 | 1-[2,6-dimethyl-4-(3-fenylprop-2-enyl)piperazin-1-yl]propan-1-on | ||
| Benzodioxolfentanyl | BZD-F; benzodioxole-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2H-1,3-benzodioxol-5-karboxamid | |
| Benzoylbenzylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid | ||
| Benzoylfentanyl | fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid | |
| Benzylfentanyl | Benzyl-F; R 4129 | N-fenyl-N-[1-(fenylmethyl)piperidin-4-yl]propanamid | |
| Benzylfuranylfentanyl | Benzyl FuF | N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid | |
| Bromadolin | U 4793e; U 47931E | 4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid | |
| Bronitazen | 2-[2-[(4-bromfenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamin | ||
| Brorfin | Brorphine | 3-{1-[1-(4-bromfenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-on | |
| Butonitazen | 2-[(4-butoxyfenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazol-1-ethanamin | ||
| 4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| Cyklopentylfentanyl | cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
| Cyklopropylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | ||
| Desmethylmoramid | R530 | 4-(4-morfolinyl)-2,2-difenyl-1-(1-pyrrolidinyl)-1-butanon | |
| Desnitazen | 1-diethylaminoethyl-2-benzyl-benzimidazol | ||
| Desomorfin | 4,5α-epoxy-17-methylmorfinan-3-ol | ||
| Despropionyl-2-fluor fentanyl | N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Despropionyl-4-fluor fentanyl | N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Dimethoxynitazen | dimetonitazene | 2-[2-[(3,4-dimethoxyfenyl)methyl]-5-nitrobenz- imidazol-1-yl]-N,N-diethylethanamin | |
| Dipyanon | 4,4-difenyl-6-(pyrrolidin-1-yl)heptan-3-on | ||
| Etazen | etodesnitazene | 2-[2-[(4-ethoxyfenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamin | |
| Ethylenoxynitazen | 2-{2-[(2,3-dihydro-1-benzofuran-5-yl)methyl]-5-nitro-1H-benzimidazol-1-yl}-N,N-diethylethan-1-amin | ||
| Ethylthionitazen | 2-[2-[(4-ethylsulfanylfenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamin | ||
| Etodesnitazepin | etodesnitazene pyrrolidine analogue | 2-[(4-ethoxyfenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)- benzimidazol | |
| Etoetonitazen | 2-[2-[[4-(2-ethoxyethoxy)fenyl]methyl]-5-nitro- benzimidazol-1-yl]-N,N-diethylethanamin | ||
| Etometazen | 5-methyl etodesnitazen; 5-methyl desnitroetonitazen | 2-[(4-ethoxyfenyl)methyl]-N,N-diethyl-5-methyl-1H-benzimidazol-1-ethanamin | |
| Etonitazepipne | N-piperidinyletonitazen | 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazol | |
| Etonitazepin | 2-[(4-ethoxyfenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzoimidazol | ||
| Etorfin | (5R,6R,7R,14R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorfinan-3-ol | ||
| Fentanyl butanamid analog | butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3-Fenylpropanoylfentanyl | β'-fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-3-fenylpropanamid | hydrocinnamoylfentanyl |
| Fluetonitazepin | 2-[[4-(2-fluorethoxy)fenyl]methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazol | ||
| Flunitazen | N,N-diethyl-2-{2-[(4-fluorfenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethanamin | ||
| 2’-Fluor-2-fluor-3-methylfentanyl | N-(1-(2-fluorfenethyl)-3-methylpiperidin-4-yl)-N-(2-fluorfenyl)propionamid | ||
| 4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorfenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
| 4-Fluor-cyklopropylbenzylfentanyl | para-fluorcyklopropylbenzylfentanyl | N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid | |
| 2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
| 3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 3-FF, m-FF |
| 4-Fluorfuranylfentanyl | para-fluorfuranylfentanyl; 4Ffuranylfentanyl | N-(4-fluorfenyl)-N-(1-fenethylpiperidin-4-yl)furan-2-karboxamid | |
| 4-Fluorisobutyrfentanyl | 4F-iBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 3-Fluormethoxyacetylfentanyl | ortho-fluormethoxyacetylfentanyl | N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 2F-viminol | 2-[di(butan-2-yl)amino]-1-[1-(2-fluorbenzyl)-1H-pyrrol-2-yl]ethan-1-ol | ||
| Furanyl UF-17 | N-[2-(dimethylamino)cyklohexyl]-N-fenyl-furan-2-karboxamid | ||
| Furanylfentanyl | FU-F; 2-furanoylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | |
| (iso)Butyryl-F-fentanyl N-benzyl analog | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | ||
| Heroin | (5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát | ||
| 4-hydroxybutyrfentanyl | 4-HO-BF; p-hydroxybutyryl fentanyl | N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid | |
| Isobutyrfentanyl | 2-methyl-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]propanamid | ||
| Isopropyl-U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid | ||
| Isotodesnitazen | 2-[2-[(4-propan-2-yloxyfenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamin | ||
| Isotonitazen | N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethan amin | ||
| Isotonitazepin | 2-[4-(2-propoxy)benzyl]-5-nitro-1-[2-(pyrrolidin-1-yl)ethyl]-1H-benzimidazol | ||
| Isotonitazepipne | 2-[4-(2-propoxy)benzyl]-5-nitro-1-[2-(piperidin-1-yl) ethyl]-1H-benzimidazol | ||
| Karbonyl-bromadol | (4-bromfenyl)-(1-(dimethylamino)-4-hydroxy-4-fenethylcyklohexyl)methanon | ||
| Ketobemidon | 1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on | ||
| Konopí | S výjimkou konopí pro léčebné použití uvedené v seznamu č. 1 | ||
| Krotonylfentanyl | (2E)-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2-butenamid | ||
| Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]butanamid | |
| 2-Methylacetylfentanyl | o-methylacetylfentanyl | N-(2-methylfenyl)-N-[1-(2-fenylethyl)-piperidin-4-yl]-acetamid | |
| 2-Methyl-AP-237 | 2-methyl-bucinnazin | 1-[2-methyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| Methylendioxynitazen | 2-(2-((1,3-benzodioxol-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amin | ||
| 3,4-Methylendioxy-U-47700 | 3,4-MDO-U-47700; 3,4-MDU-47700; MDU-47; MDU-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methylbenzo[d][1,3]dioxol-5-karboxamid | |
| α-Methylfentanyl butanamid analog | BF; B-F | 2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
| 3-Methylkrotonylfentanyl | β'-methylkrotonylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid | |
| Methylnitazen | menitazene | 2-[2-[(4-methylfenyl) methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamin | |
| Methylthionitazen | 2-[2-[(4-methylsulfanylfenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamin | ||
| Metodesnitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]benzimidazol-1-yl]ethanamin | ||
| Metodesnitazepin | 2-(4-methoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazol | ||
| Metonitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamin | ||
| Metonitazepin | 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazol | ||
| Metonitazepipne | 2-(4-methoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazol | ||
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | ||
| N-desethyl etonitazen | 2-[2-[(4-ethoxyfenyl)methyl]-5-nitro-benzimidazol-1-yl]-N-ethyl-ethanamin | ||
| N-desethyl isotonitazen | N-ethyl-2-[2-[(4-isopropoxyfenyl)methyl]-5-nitro-benzimidazol-1-yl]ethanamin | ||
| N-methyl U-47931E | N-methylbromadolin | 4-brom-N-(2-(dimethylamino)cyklohexyl)-N-methylbenzamid | |
| N,N-dimethylamino etonitazen | 2-[2-[(4-ethoxyfenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-dimethylethanamin | ||
| Nitazen | 2-(2-benzyl-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethanamin | ||
| Nortilidin | ethyl 2-methylamino-1-fenylcyklohex-3-en-1-karboxylát | ||
| O-AMKD; acetoxymethylketobemidon | 3-(4-acetyl-1-methylpiperidin-4-yl)fenyl acetát | ||
| OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Piperidylthiambuten | piperidinohton, PBN, 127C49 | 1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)piperidin | |
| Protonitazen | N,N-diethyl-5-nitro-2-[(4-propoxyfenyl)methyl]-1-H-benzimidazol-1-ethanamin | ||
| Protonitazepin | 5-nitro-2-[(4-propoxyphenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)benzimidazole | ||
| Protonitazepipne | 2-[(4-propoxyfenyl)methyl]5-nitro-1-(2-piperidin-1-ylethyl)benzimidazol | ||
| Pryskyřice z konopí | |||
| Spirochlorfin | R6890 | 8-[1-(4-chlorfenyl)ethyl]-1-fenyl-1,3,8-triazaspiro[4.5]dekan-4-on | |
| Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
| Tetramethylcyklopropanfentanyl | TMCP-fentanyl; TMCP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyklopropan-1karboxamid | |
| Thiofenfentanyl | 2-thiofuranyl fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid | |
| 4-(Trifluormethyl) U-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methyl-4-(trifluormethyl)benzamid | ||
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-48800 | 2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-50488 | 3,4-dichlor-N-methyl-N-[2-(1-pyrrolidinyl)cyklohexyl] benzenacetamid | ||
| U-51754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | ||
| Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl pentanamid analog |
Including salts of narcotic substances listed in this group in all cases where such salts may exist.
Příloha č. 4
Annex No. 4 to Government Decree No. 463 / 2013 Coll.
List No 4 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| 1-(Cyklohexylmethyl)-2-[(4-ethoxyfenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-karboxamid | |||
| (+)-Lysergid | LSD, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 1-(2-(Methylamino)propanoyl)naftalen | AMAPN | 2-(methylamino)-1-(naftalen-1-yl)propan-1-on | |
| 1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
| 1-Nafýron | 1-naphyrone | 1-naftalen-1-yl-2-pyrrolidin-1-yl-pentan-1-on | |
| 1p-LSD, 1P-LAD | diethylamid kyseliny 1-propionyl lysergové; (6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid | ||
| 2,3-Dimethylmetkathinon | 2,3-DMMC | 1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2,3-Methylendioxymethkathinon | 2,3-MDMC | 1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on | |
| 2,4,5-Trimethylmethkathinon | 2,4,5-TMMC | ||
| 2,4,6-Trimethoxyamfetamin | TMA-6 | 1-(2,4,6-trimethoxyfenyl)propan-2-amin | |
| 2,4-Dimethylethkathinon | 2,4-DMEC | 1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on | |
| 2,4-Dimethylmetkathinon | 2,4-DMMC | 1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2',4'-Dimethyl-α-pyrrolidinpropiofenon | 2,4-DMPPP | 1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on | |
| 2,5-Dimethoxy-4-chloramfetamin | DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-jodamfetamin | DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | |
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | Cimbi-36 | |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | 2C-C-NBOMe | |
| 25I-NBF; 25I-NB2F; 2C-I-NBF, NBF-2C-I; Cimbi-21 | 2-(4-jod-2,5-dimethoxyfenyl)-N[(2-fluorfenyl)methyl]ethylamin | ||
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-I-NBOH; Cimbi-27 | |
| 251-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N[(2-methoxyfenyl)methyl]ethanamin | NBOMe-2C-I | |
| 2-Brommethkathinon | 2-BMC | (RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on | |
| 2C-B-FLY | 2C-B-FLY | 2-(4-brom-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamin | |
| 2C-D | 2C-D | 2,5-dimethoxy-4-methylfenethylamin | LE-25 |
| 2C-E | 2C-E | 2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin | |
| 2-Ethylmethkathinon | 2-EMC | (RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on | |
| 2-Fluoramfetamin | 2-FA | 1-(2-fluorfenyl)propan-2-amin | |
| 2-Fluordeschlorketamin | 2-Fl-2'-Oxo-PCM, fluoro-ketamine 2-FDCK, 2-FDK, 2-FK | 2-(2-fluorfenyl)-2-methylamino-cyklohexanon | |
| 2-Fluorethamfetamin | 2-FEA; 2-fluoroethamphetamine | N-ethyl-1-(2-fluorfenyl)propan-2-amin | |
| 2-Fluorethkathinon | 2-FEC | 1-(2-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Fluormethamfetamin | 2-FMA | (RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin | |
| 2-Fluormethkathinon | 2-FMC | 1-(2-fluorfenyl)-2-(methylamino)propan-1-on | |
| 2F-QMPSB; SGT-13 | 8-chinolinyl-3-[(4,4-difluoφiperidin-1-yl)sulfonyl]-4-methylbenzoát | ||
| 2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
| 2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
| 2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
| 2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | ||
| 2-Methoxymethylon | N-methyl-bk-MMDA-2 | 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-on | |
| 2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
| 2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
| 2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
| 2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
| 2-Pyrrolidin-3-methoxy-propiofenon | α-PPP-MeO; PMeOPP | 3-methoxy-1-fenyl-2-(pyrrolidin-1-yl)propan-1-on | |
| 3-(4-Hydroxymethylbenzoyl)-1-pentylindol | Tai High | [4-(hydroxymethyl)fenyl]-(1-pentyl-1H-indol-3-yl)methanon | |
| 3-(p-Methoxybenzoyl)-N-methylindol | (4-methoxyfenyl)(l -methyl-1H-indol-3-yl)methanon | ||
| 3',4'- Methylendioxy-α-methyl PPP | MDMPP | 1-(3,4-methylendioxyfenyl)-2-methyl-2-pyrrolidinylpropan-1-on | |
| 3,4-Dichlorethkathinon | 3,4-DCEC; | 1-(3,4-dichlorfenyl)-2-(ethylamino)propan-1-on | |
| 3,4-Dichlormethylfenidát | 3,4-CTMP | methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-pipendin-2-yl]acetát | |
| 3,4-Dichlor-N,N-cyklohexylmethylmeth-kathinon | 3,4-DCCHMMC | 2-(cyklohexylmethylamino)-1-(3,4-dichlorfenyl)propan-1-on | |
| 3,4-Dimethoxy-α-PHP | 3,4-DMeO-α-PHP | 1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)hexan-1-on | |
| 3,4-Dimethylethkathinon | 3,4-DMEC | 1-(3,4-dimethylfenyl)-2-(ethylamino)propan-1-on | |
| 3,4-Dimethylmetkathinon | 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 3,4-Dimethyoxy-α-pyrrolidinovalerofenon | 3,4-DMeO-α-PVP | 1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 3,4-Methylendioxypyrovaleron | MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | MDPK |
| 3',4'-Methylendioxy-α-pyrrolidinbutyro-fenon | MDPBP | (RS)-1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)butan-1-on | |
| 3 ',4'-Methylendioxy-α-PPP | MDPPP | 1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 3 -Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
| 3-Ethylmethkathinon | 3-EMC | (RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on | |
| 3F-Fenmetrazin | 3-FPM; PAL-593 | 2-(3-fluorofenyl)-3-methylmorfolin | |
| 3-Fluoramfetamin | 3-FA | 1-(3-fluorfenyl)propan-2-amin | |
| 3-Fluorethamfetamin | 3-FEA; 3-fluoroethamphetamine | N-ethyl-1-(3-fluorfenyl)propan-2-amin; N-ethyl-3-fluoramfetamin | |
| 3-Fluorethkathinon | 3-FEC | 1-(3-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Fluormethamfetamin | 3-FMA | (RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin | |
| 3-Fluormethkathinon | 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | |
| 3-Fluor-α-PVP | 3F-α-PVP; 3F-PVP | 1-(3-fluorfenyl)-2-(1-pyrrolidin)pentan-1-on | 3-Fluor-α-PVP |
| 3-Hydroxyfenazepam | 3-HOP, HPNZ, 3-oxyfenazepam, 3 -hy droxy fenazepam | 7-brom-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| 3-Hydroxyfencyklidin | 3-HO-PCP; 3-hydroxyphencyclidine | 3-[1-(piperidin-1-yl)cyklohexyl] fenol | |
| 3-Chloramfetamin | 3-CA | 1-(3-chlorfenyl)propan-2-amin | |
| 3-Chlorethkathinon | 3-CEC | 1-(3-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Chlormethamfetamin | 3-CMA | 1-(3-chlorfenyl)-N-methylpropan-2-amin | |
| 3-Chlormethkathinon | 3-CMC | 1-(3-chlorfenyl)-2-(methylamino)propan-1-on | |
| 3-Chlorpentedron | 3-CPD | 1-(3-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 3-MAPB | 1-(benzofuran-3-yl)-N-methylpropan-2-amin | ||
| 3-Methoxy eticyklidin | 3-MeO-PCE | N-ethyl-1-(3-methoxyfenyl)cyklohexan-1-amin | |
| 3-Methoxy fencyklidin | 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | |
| 3-Methoxymethkathinon | 3-MeOMC | 1-(3-methoxyfenyl)-2-(methylamino)propan-1-on | |
| 3-Methyl-4-fluormethkathinon | 3-Methylflefedron | 1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on | |
| 3-Methylamfetamin | 3-MA | (2RS)-1-(3-methylfenyl)propan-2-amin | |
| 3-Methylethkathinon | 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | |
| 3-Methylmetamfetamin | 3-MMA | 1-(3-methylfenyl)-N-methylpropan-2-amin | |
| 3-Methylmetkathinon | 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | |
| 3-Methyl-N,N-dimethylkathinon | 3-MDMC | 1-(3-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 3-Methyl-N-ethylnorpentedron | 3-MEAP | 2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on | |
| 3-Methylthioamfetamin | 3-MTA | (2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin | |
| 4'-Fluor-4-methylaminorex | 4-FPO; p-F-4-methylaminorex | 5-(4-fluorfenyl)-4,5-dihydro-4-methyl-2-oxazolamin | |
| 4'-Methyl-N-isopropylpentedron | 4'-methyl-NiPP | 1-(4-methylfenyl)-2-(1-methylethylamino)pentan-1-on | |
| 4'-Methyl-α-pyrrolidinbutyrofenon | MPBP | (RS)-1-(4-methylfenyl)-2-(pyrrohdin-1-yl)butan-1-on | |
| 4'-Methyl-α-pyrrolidinisohexanofenon | 4'-methyl-α-PiHP | 4-methyl-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4'-Methyl-α-pyrrolidinpropiofenon | 4'-methyl-α-PPP; MPPP | (RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4'-Ethyl-α-PVP | 4'-ethyl-α-pyrrolidinopentiofenon | 1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Acetoxy-N-methyl-N-ethyltryptamin | 4-AcO-MET | {3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát | |
| 4-Bromethkathinon | 4-BEC | 1-(4-bromfenyl)-2-(ethylamino)propan-1-on | |
| 4-Brommethkathinon | 4-BMC | (RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on | Brefedron |
| 4-Brom-α-pyrrolidinvalerofenon | 4Br-α-PVP | 1-(4-bromfenyl)-2-pyrrolidin-1-yl-pentan-1-on | |
| 4-Brom-α-pyrrolidinpropiofenon | 4Br-α-PPP; pBPPP, 4Br-PPP | 1-(4-bromfenyl)-2-pyrrolidin-1-yl-propan-1-on | |
| 4-Ethylethkathinon | 4-EEC | 2-(ethylamino)-1-(4-ethylfenyl)propan-1-on | |
| 4-Ethylmethkathinon | 4-EMC | (RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on | |
| 4F-Fenmetrazin | 4-FPM | 2-(4-fluorofenyl)-3-methylmorfolin | |
| 4-Fluoramfetamin | 4-FA | 1-(4-fluorfenyl)propan-2-amin | |
| 4-Fluorbufedron | 1-(4-fluorfenyl)-2-(methylamino)butan-1-on | ||
| 4-Fluorethkathinon | 4-FEC | 1-(4-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Fluorethylfenidát | 4F-EPH; p-fluoroethylphenidate | ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | |
| 4-Fluorkathinon | 4-FC | 2-amino-1-(4-fluorfenyl)-propan-1-on | |
| 4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
| 4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron |
| 4-Fluormethylfenidát | 4F-MPH; 4-FMPH | Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | 4F-TMP |
| 4-Fluor-N-ethylbufedron | 4F-NEB | 2-(ethylamino)-1-(4-fluorfenyl)butan-1-on | |
| 4-Fluor-N-ethylpentedron | 4F-NEP; 4-fluor-α-ethylamino-pentiofenon | 2-(ethylamino)-1-(4-fluorfenyl)pentan-1-on | |
| 4-Fluor-N-isopropylnorpentedron | 4F-IPV; 4F-NPP; 4F-NIPP | 1-(4-fluorfenyl)-2-(1-methylethylamino)pentan-1-on | |
| 4-Fluorpentedron | 4-FPD; 4-F-pentedron | 1-(4-fluorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Fluor-α-pyrrolidinvalerofenon | 4-fluoro-α-PVP; 4F-PVP; O-2370 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Fluor-α-pyrrolidinbutiofenon | 4F-PBP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)butan-1-on | |
| 4-Fluor-α-pyrrolidinenanthofenon | 4F-α-PEP; 4F-PV8 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)heptan-1-on | |
| 4-Fluor-α-pyrrolidinhexanofenon | 4-F-α-PHP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)hexan-1-on | |
| 4-Fluor-α-pyrrolidinisohexanofenon | 4F-alpha-PHiP; 4F-α-PiHP | 1-(4-fluorfenyl)-4-methyl-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Fluor-α-pyrrolidinoktanofenon | 4F-α-POP; 4F-PV9 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)oktan-1-on | |
| 4F-MDMB-BICA | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 4F-MDMB-BINACA; 4F-ADB | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 4-F-α-PVP piperidin analog | 1-(4-fluorfenyl)-2-(1-piperidyl)pentan-1-on | ||
| 4-HTMPIPO | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on | ||
| 4-Hydroxy-N-methyl-N-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Methylcybin |
| 4-Hydroxy-N-methyl-N-isopropyl tryptamin | 4-HO-MiPT | 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol | Miprocin |
| 4-Chlor-α-pyrrolidinovalerofenon | 4-Cl-α-PVP | 1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Chloramfetamin | 4-CA | 1-(4-chlorfenyl)propan-2-amin | PCA |
| 4-Chlordiazepam | Ro5-4864, chlorodiazepam | 7-chlor-5-(4-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| 4-Chlorethkathinon | 4-CEC | 1-(4-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Chlorisopropylkathinon | 4-CIC; clipredrone, | 1-(4-chlorfenyl)-2-(isopropylamino)propan-1-on | |
| 4-Chlormethamfetamin | 4-CMA | 1-(4-chlorfenyl)-N-methylpropan-2-amin | p-CMA |
| 4-Chlormethkathinon | 4-CMC | 1-(4-chlorfenyl)-2-(methylamino)propan-1-on | Clefedron |
| 4-Chlor-N,N-dimethylkathinon | 4-CDC; 4-CDMD | 1-(4-chlorfenyl)-2-(N,N-dimethylamino)propan-1-on | |
| 4-Chlor-N-butylkathinon | 4-CBC | 2-(butylamino)-1-(4-chlorfenyl)propan-1-on | 4-Chlorbutylkathinon |
| 4-Chlorpentedron | 4-CPD | 1-(4-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlor-α-pyrrolidinpropiofenon | 4-chlor-α-PPP | 1-(4-chlorfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4-MAPB | 4-MAPB | 1-(benzofuran-4-yl)-N-methylpropan-2-amin | |
| 4-Methoxy-α-pyrrolidinbutiofenon | 4-MeO-α-PBP; 4-MOPBP | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)butan-1-on | |
| 4-Methoxy-α-pyrrolidinenanthofenon | 4-MeO-α-PEP; 4-MeO-α-PV8 | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)heptan-1-on | |
| 4-Methoxy-α-pyrrolidinoktanofenon | 4-methoxy α-POP; 4-MeO-α-PV9 | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)oktan-1-on | |
| 4-Methoxy-α-pyrrolidinpentiofenon | 4-MeO-α-PVP | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4'-Methoxy-α-pyrrolidinpropiofenon | 4'-Methoxy-α-PPP; MOPPP | (RS)-1-(4-methoxyfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4-Methylamfetamin | 4-MA | (2RS)-1-(4-methylfenyl)propan-2-amin | |
| 4-Methylbufedron | 4-Me-MABP | 2-(methylamino)-1-(4-methylfenyl)butan-1-on | |
| 4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methylkathinon | Normefedron; 4-MC | 2-amino-1-(4-methylfenyl)propan-1-on | |
| 4-Methylmetamfetamin | 4-MMA | 1-(4-methylfenyl)-N-methylpropan-2-amin | |
| 4-Methylmetkathinon | Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methyl-N,N-diethylkathinon | 2-diethylamino-1-(4-methylfenyl)propan-1-on | ||
| 4-Methyl-N,N-dimethylkathinon | 4-MDMC | 1-(4-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 4-methyl-N-benzylkathinon | (4-MBC) | (±)-1-(4-methylfenyl)-2-(benzylamino)propan-1-on | |
| 4-Methyl-N-ethylnorpentedron | 4-MEAP | 2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on | |
| 4-Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
| 4'-Methyl-α-pyrrolidinhexanofenon | MPHP | (RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)hexan-1-on | |
| 4-MPD | 1-(4-methylfenyl)-2-methylamino-pentan-1-on | ||
| 5 - Aminopropylindol | 5-API | 5-(2-aminopropyl)indol | |
| 5-BPDi; indanyl-α-PHP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| 5C-AKB48; 5C-APINACA | N-(1-adamantyl)-1-(5-chlorpentyl)indazol-3-karboxamid | ||
| 5Cl-AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-chlorpentyl)indazol-3-karboxamid | ||
| 5Cl-MDMB-PINACA; 5Cl-ADB | methyl 2-{[1-(5-chlorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát | ||
| 5-Cl-pentyl JWH 018 indazol analog | 5Cl-THJ-018; 5Cl-JWH-018-N, THJ-018 chloro analogue | [1-(5-chlorpentyl)-1H-indazol-3-yl](naftalen-1-yl)methanon | |
| 5 -Dihydrobenzofuranpyrovaleron | 5-DBFPV; MBPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin | ||
| 5F-3,5-AB-PFUPPYCA; 5F-3,5-AB-FUPPYCA, AZ-037 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid | ||
| 5F-5,3-AB-PFUPPYCA; 5F-AB-FUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-5-(4-fluorfenyl)-1H-pyrazol-3-karboxamid | ||
| 5F-AB-P7AICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | ||
| 5F-AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AKB57 | adamantan-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-AMBICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-AMB-PICA | methyl (2S)-2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methylbutanoát | ||
| 5F-AMB-PINACA; 5F-AMB | methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP | |
| 5F-A-P7AICA | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | ||
| 5F-APP-PICA | N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-APP-PINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluorpentyl)indazol-3-karboxamid | ||
| 5F-CUMYL-PEGACLONE | 5-(5-fluorpentyl)-2-(1-methyl-1-fenylethyl)-pyrido[4,3-b]indol-1-on | ||
| 5F-EDMB-PINACA | ethyl 2-{[1-(5-fluorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát | ||
| 5F-EMB-PINACA | ethyl 2-[[1-(5-fluorpentyl)indazol-3-karbonyl]amino]-3-methyl-butanoát | ||
| 5F-JWH-398; CL-2201; JWH-398 N-5-fluor pentyl analog | (4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon | ||
| 5F-MDMB-P7AICA | methyl-2-{[1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethyl butanoát | ||
| 5F-MDMB-PICA; 5F-MDMB-2201 | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 5F-MDMB-PINACA; 5F-ADB | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 5F-NNEI-2 | 1-(5-fluorpentyl)-N-(naftalen-2-yl)-1H-indol-3-karboxamid | ||
| 5F-PB-22 indazol analog | chinolin-8-yl 1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-PB-22; 5F-QUPIC | 8-chinolinyl ester kyseliny 1-(5-fluorpentyl)-1H-indol-3-karboxylové | ||
| 5-F-pentyl-3-pyridinoylindol | [1-(5-fluorpentyl)-1H-indol-3-yl] (pyridin-3-yl)methanon | ||
| 5F-PY-PICA | 1-(5-fluorpentyl)-3-(pyrrolidin-1-karbonyl)-1-H-indol | ||
| 5F-PY-PINACA | [1-(5-fluorpentyl)indazol-3-yl]-pyrrolidin-1-yl-methanon | ||
| 5F-SDB-005 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-SDB-006 | N-benzyl-1-(5-fluorpentyl)-l H-indol-3-karboxamid | ||
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyklopropyl)methanon | XLR-11 | |
| 5-MAPB | 1-(benzofuran-5-yl)-N-methylpropan-2-amin | ||
| 5-MeO-AMT | 5 -methoxy-α-methyltryptamin | ||
| 5-MeO-DALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin | ||
| 5-MeO-MiPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-methoxy-N-methyl-N-iso-propyl tryptamin | ||
| 5-MethoxymethyIon | N-methyl-bk-MMDA-5 | 1-(7-methoxybenzo[d] [1,3]dioxol-5-yl)-2-(methylamino)propan-1-on | |
| 5-PPDi | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-on | ||
| 6-APB | 6-(2-aminopropyl)benzofuran | ||
| 6-EAPB | 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin | ||
| 6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amin | ||
| 7-MAPB | 1-(benzofuran-7-yl)-N-methylpropan-2-amin | ||
| A-796,260 | [1-(2-morfolin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| A-796,260 izomer | ((E)-1-(1-(2-morfolm-1-yl)ethyl)indol-3-yl)-3,4,4-tnmethylpent-2-en-1-on | ||
| A-834,735 | 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| A-836,339 | N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-yliden]-2,2,3,3-tetramethylcyklopropan-karboxamid | ||
| AB-005 | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)-methanon | ||
| AB-005 azepan izomer | (1-(1-methylazepan-2-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| AB-FUBINACA 2-fluorbenzyl izomer | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-[(2-fluorfenyl)methyl]-1H-indazol-3-karboxamid | ||
| AB-CHMFUPPYCA; 3,5-AB-CHMFUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid | ||
| AB-CHMINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-l(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid | ||
| AB-PINACA N-(2-fluorpentyl) izomer | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorpentyl)-1H-indazol-3-karboxamid | ||
| Adamantyl-THPINACA | N-(1-adamantyl)-1-(tetrahy dropyran-4-ylmethyl)indazol-3-karboxamid | ||
| ADB-BUTINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazol-3-karboxamid | ||
| ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| ADB-CHMICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-1H-indol-3-karboxamid | ||
| ADB-CHMINACA | N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karbox-amid | ||
| ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karboxamid | ||
| ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-\H- indazol-3-karboxamid | ||
| Adinazolam | U 41123 | 1-(8-chlor-6-fenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethan amin | |
| A-CHMINACA | N-(1-adamantyl)-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| AKB-57 | Adamant-1-yl-1-pentylindazol-3-karboxylát | ||
| AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid | 6-allyl-6-nor-LSD | |
| Alprazolam triazolbenzofenon derivát | (2-(3-(aminomethyl)-5-methyl-4-H-1,2,4-triazol-4-yl)-5-chlorfenyl)(fenyl)methanon | ||
| AM-1220 | 1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naftyl)-methanon | ||
| AM-1220 azepan izomer | 1-(1-methylazepan-3-yl)-1H-indol-3-yl] (naftyl)methanon | ||
| AM-1248 | adamant-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanon | ||
| AM-1248 azepan izomer | adamant-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanon | ||
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| AM-2201 benzimidazol analog; FUBIMINA | (1-(5-fluorpentyl)-1H-benzo[d]imidazol-2-yl)(naftalen-1-yl)methanon | ||
| AM-2201 indazol karboxamid analog | N-1-naftalenyl-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| AM-2232 | 5-[3-(1-naftoyl)-1H-indol-1-yl]pentannitril | ||
| AM-2233 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodbenzoyl)indol | ||
| AM-6527 | 1-pentyl-N-(naftalen-1-yl)-1H-indol-3-karboxamid | ||
| AM-6527 5-fluorpentyl derivát | 1-(5-fluorpentyl)-N-(naftalen-1-yl)-1H-indol-3-kaboxamid | ||
| AM-679 | (2-iodfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| AM-694 | 1-[(5-fluorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon | ||
| AM-694 (ethyl nahrazuje iod) | 1-(5-fluorpentyl)-3-(2-ethylbenzoyl)indol | ||
| AM-694 (methyl nahrazuje iod) | 1-(5-fluorpentyl)-3-(2-methylbenzoyl)indol | ||
| AM-694 chlor derivát | 1-[(5-chlorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon | ||
| AMB-4en-PICA | methyl-3-methyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-karboxamido]butanoát | ||
| AMB-FUBICA | methyl 2-[[1-[(4-fluorfenyl)methyl]indol-3-karboxamid]-3-methylbutanoát | ||
| AMB-FUBINACA; FUB-AMB | Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát | MMB-FUBINACA | |
| AMB-CHMICA | Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát | ||
| AMB-CHMINACA | methyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát | ||
| APICA; SDB-001, 2NE1 | N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid | ||
| APINACA | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | AKB48 | |
| APP-BINACA | N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-butyl-1H-indazol-3-karboxamid | ||
| APP-FUBINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| APP-CHMINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(cyklohexylmethyl)indazol-3-karboxamid | ||
| bk-2C-B; βk-2C-B | 2-amino-1-(4-brom-2,5-dimethoxyfenyl)ethan-1-on | ||
| bk-IVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-on | ||
| bk-PBDB | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-on | ||
| bk-PMA | 2-amino-1-(4-methoxyfenyl)propan-1-on | ||
| BMDB | 2-benzylamino-1-(3,4-methylendioxyfenyl)butan-1-on | ||
| BMDP; 3,4-MDBC | 2-benzylamino-1-(3,4-methylendioxyfenyl)propan-1-on | ||
| Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
| Bromazolam | 8-brom-6-fenyl-1-methyl-4H-benzo[f][1,2,4]triazol[4,3-a][1,4]diazepin | ||
| Bromo-Dragonfly | (2R)-1-(4-bromfuro[2,3-f][1]benzofuran-8-yl)propan-2-amin | ||
| Butylon | Bk-MBDB | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on | |
| CBL-018 | naftalen-1-yl 1-pentyl-1H-indol-3-karboxylát | ||
| CP 47,497 | 2-[(1S,3R)-3-hydroxycyklohexyll-5-(2-methyloktan-2-yl)fenol | ||
| CP 47,497 (C8 + C2) | 2-((1S,3R)-3-hydroxycyklohexyl)-5-(2-methylnonan-2-yl)fenol; 2-((1S,3R)-3-hydroxycyklohexyl)-5-(dekan-3-yl)-fenol | 1,1-dimethyl a 1-ethyl derivát C8-homologu | |
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 | |
| CUMYL-4CN-B7AICA | 1-(4-kyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid | ||
| CUMYL-4CN-BINACA; SGT-78 | 1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid | ||
| CUMYL-5F-P7AICA | 1-(5-fluorpentyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid | ||
| CUMYL-5FPICA | 1-(5-fluorpentyl)-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-5FPINACA | 1-(5-fluorpentyl)-N-(1-methyl-1-fenyethyl)-1H-indazol-3-karboxamid | ||
| CUMYL-BICA | 1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-CH-MEGACLONE | 5-(cyklohexylmethyl)-2-(1-methyl-1-fenyl-ethyl)pyrido[4,3-b]indol-1-on | ||
| CUMYL-PEGACLONE; SGT-151 | 2-(1-methyl-1-fenylethyl)-5-pentyl-pyrido[4,3-b]indol-1-on | ||
| CUMYL-PICA | 1-pentyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-PINACA | 1-pentyl-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | ||
| CUMYL-THPINACA | N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1-H-indazol-3-karboxamid | ||
| DBZP | 1,4-dibenzylpiperazin | ||
| Deschloretizolam | ETZ-2; etizolam-2 | 2-ethyl-9-methyl-4-fenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Deschlorketamin | 2-(methylamino)-2-fenylcyklohexan-1-on | ||
| Deschlor-N-ethyl-ketamin | O-PCE; 2-Oxo-PCE, eticyclidone | 2-(ethylamino)-2-fenylcyklohexan-1-on | |
| Dibutylon | Bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon | Methylbutylon |
| Diclazepam | 2-chlorodiazepam | 7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | Ro 5-3448 |
| Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl] amin | |
| Difenidin | DPD; 1,2-DEP; DIPH | 1-(1,2-difenylethyl)piperidin | AC1L4H21 |
| Difludiazepam | Ro 07-4065 | 7-chlor-5-(2,6-difluorfenyl)-1-methyl-3H-1,4-benzodiazepin-2-on | |
| Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylpentedron | DL-4662 | 1-(3,4-dimethoxyfenyl)-2-(ethylamino)pentan-1-on | |
| Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethoxymetamfetamin | STP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
| Dimethoxypropylthiofenethylamin | 2C-T-7 | [4-(propylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethylheptyltetrahydrokanabinol | DMHP | 3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Dimethylon | Bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-on | 3,4-methylendioxydi- methylkathinon |
| Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
| Dipentylon | 2-(dimethylamino)-3΄,4΄-(methylendioxy)valerophenone | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-pentan-1-on | |
| DMBA-CHMINACA | 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethylbutanová kyselina | ||
| EAM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl]-(4-ethyl-naftalen-1-yl)methanon | ||
| Efenidin | NEDPA; ephenidine; EPE | N-ethyl-1,2-difenylethylamin | |
| EG-018 | naftalen-1-yl(9-pentyl-9H-karbazol-3-yl)methanon | ||
| EG-2201 | (9-(5-fluorpentyl)-9H-karbazol-3-yl)(naftalen-1-yl)methanon | ||
| EMB-FUBINACA | Ethyl 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3-methyl-butanoát | ||
| Ephylon | MDEVP; bk-EBDP | 1-(benzo[d] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on | N-ethyl-pentylon |
| Ethkathinon | Ethylpropion; N-ethylcathinone; ETH-CAT | 2-ethylamino-1-fenyl-propan-1-on | |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid | ||
| Ethylfenidát | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | ||
| Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Etizolam | AHR 3219; Depas | 4-(2-chlorfenyl)-2-ethyl-9-methyl-67/-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Etryptamin | 3-(2-aminobutyl)indol | ||
| Eutylon | bk-EBDB, N-Ethylbutylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-on | |
| FDU-PB-22 | 1-naftyl 1-[(4-fluorfenyl)methyl]indol-3-karboxylát | ||
| Fenibut | phenibut | 4-amino-3-fenylbutanová kyselina | |
| Flualprazolam | Ro 11-5073/000 | 8-chlor-6-(2-fluorfenyl)-1-methyl -4H- [1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| Flubromazepam | 7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Flubromazolam | 8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]triazolo-[4,3a] [1,4]benzodiazepin | ||
| Fluklotizolam | 2-chlor-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4] diazepin | ||
| Flunitrazolam | 6-(2-fluorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | ||
| Fonazepam | Ro 05-4435 | 5-(2-fluorfenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-on | |
| FUB-144 | [1-[(4-fluorfenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| FUB-AKB48 | N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| FUB-JWH-018 | (1-(4-fluorbenzyl)-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| FUB-NPB-22 | chinolin-8-yl-(4-fluorbenzyl)-1H-indazol-3-karboxylát | ||
| FUB-PB-22 | chinolin-8-yl-1-(4-fluorbenzyl)-1H-indol-3-karboxylát | ||
| Hexedron | β-propylmethcathinone | 2-(methylamino)-1-fenylhexan-1-on | |
| Hexylon | βk-MBDH | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)hexan-1-on | |
| HU-210 | (6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloktan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | ||
| HU-331 | 3S,4R-p-benzochinon-3-hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl | ||
| Hydroxytenamfetamin | (2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| Indapyrofenidon | 1-(2,3-dihydro-1H-inden-5-yl)-2-fenyl-2-(pyrrolidin-1-yl)-ethanon | ||
| Ioddimethoxyfenethylamin | 2C-I | (4-iod-2,5-dimethoxyfenylethyl)amin | |
| Isohexedron | 4-methyl-2-(methylamino)-1-fenylpentan-1-on | ||
| Isopropylfenidát | IPPD | isopropyl2-fenyl-2-(2-piperidyl)acetát | |
| JTE-907 | N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-karboxamid | ||
| JWH 018 N-5-brompentyl derivát | [1-(5-brompentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH 018 N-5-chlorpentyl derivát | [1-(5-chlorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH-007 | 1-pentyl-2-methyl-3-(1-naftoyl)indol | ||
| JWH-018 | (naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-018 adamantoyl derivát; AB-001 | 1-pentyl-3-(adamant-1-oyl)indol | ||
| JWH-018 cyklohexymethyl derivát | [1-(cyklohexylmethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| JWH-018 chinolinkarboxylát analog; PB-22 | chinolin-8-yl-1-pentyl-1H-indol-3-karboxylát | ||
| JWH-018 indazol analog | 1-naftalenyl(1-pentyl-1H-indazol-3-yl)-methanon | ||
| JWH-019 | 1-hexyl-3-(1-naftoyl)indol | ||
| JWH-022 | naftalen-1-yl(2-(pent-4-enyl)-1H-indol-3-yl)methanon | ||
| JWH-030 | naftalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanon | ||
| JWH-071 | (1-ethyl-1H-indol-3-yl)-1-naftalenyl-methanon | ||
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-073 methyl derivát | 1-butyl-3-(1-(4-methyl)naftoyl)indol) | ||
| JWH-081 | (4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 pentenyl 2-methylindol derivát | (4-methylnaftalen-1-yl)(2-methyl 1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-122 pentenyl derivát | (4-methylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-145 | naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)methanon | ||
| JWH-182 | 1-pentyl-3-(4-propyl-1-naftoyl)indol | ||
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| JWH-203 | 2-(2-chlorfenyl)-1-(1-pentylindol-3-yl)ethanon | ||
| JWH-210 | (4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-250 | 2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | ||
| JWH-2501 2-methylen-N-methyl-piperidyl derivát | 1-(2-methylen-N-methylpiperidyl)-3-(2-methoxyfenylacetyl)indol | ||
| JWH-251 | 2-(2-methylfenyl)-1-(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-302 | 1-pentyl-3-(3-methoxyfenylacetyl)indol | ||
| JWH-307 | (5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmethanon | ||
| JWH-307 brom derivát | (5-(2-bromfenyl)-1-pentyl-1H-pyrrol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-368 | [5-(3-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-methanon | ||
| JWH-370 | [5-(2-methylfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-methanon | ||
| JWH-387 | 1-pentyl-3-(4-brom-1-naftoyl)indol | ||
| JWH-398 | (4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-412 | 1-pentyl-3-(4-fluor-1-naftoyl)indol | ||
| JWH-412 5-fluorpentyl derivát | (4-fluornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]methanon | ||
| JWH-methylcyklohexan-8-chinolinol; BB-22 | chinolin-8-yl 1-(cyklohexylmethyl)-1H-indol-3-karboxylát | ||
| Kathinon | (2S)-2-amino-1-fenylpropan-1-on | ||
| Klobromazolam | phenazolam; BRN 4550445 | 8-brom-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| Klonazolam | 6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Kloniprazepam | 5-(2-chlorfenyl)-1-(cyklopropylmethyl)-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-on | ||
| LTI-701 | 1-(5-fluorpentyl)-N-fenyl-indol-3-karboxamid | ||
| LY2183240 | N,N-dimethyl-5-[(4-bifenyl)methyl]tetrazol-1-karboxamid | ||
| M5FPIC | methyl-1-(5-fluorpentyl)-1H-indol-karboxylát | ||
| MAM-2201 | 1-(5-fluorpentyl)-3-(4-methyl-naftoyl)indol | ||
| MAM-2201 chlorpentyl derivát | [1-(5-chlorpentyl)-1H-indol-3-yl](4-methyl-naftalen-1-yl)-methanon | ||
| MBA-CHMINACA | 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3-methylbutanová kyselina | ||
| MBZP | 1 -benzyl-4-methylpiperazin | ||
| MDA 19 | N-[(Z)-(1-hexyl-2-oxoindol-3-yliden)amino]benzamid | ||
| MDAI | 5,6-(methylendioxy)indan-2-amin | ||
| MDMB-4en-PINACA | (methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido) butanoát) | ||
| MDMB-FUBICA | methyl 2-(1-(4-fluorbenzyl)-1H-indol-3-karboxamid)-3,3-dimethylbutanoát | ||
| MDMB-FUBINACA | 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3,3-dimethylbutanoát | ||
| MDMB-CHMCZCA | methyl 2-(9-(cyklohexylmethyl)-9H-karbazol-3-karboxamido)-3,3-dimethylbutanoát | ||
| MDMB-CHMICA | N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl ester | ||
| MDMB-PCZCA | methyl 3,3-dimethyl-2-(9-pentyl-9 H-karbazol-3-karboxamido)butanoát | ||
| MDPHP; 3,4-MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| Meklonazepam | (S)-5-(2-chlorfenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Mepirapim | (4-methylpiperazin-1-yl)-(1-pentylindol-3-yl)methanon | ||
| Meskalin | 3,4,5-trimethoxyfenethylamin | ||
| Metamfepramon | Dimethylkathinon, Dimethylpropion | 2-dimethylamino-1-fenylpropan-1-on | |
| Methamnetamin | methylnaphetamine, N-methyl-PAL-287; MNT; MNA | N-methyl-1-(naftalen-2-yl)propan-2-amin | |
| Methanandamid | N-(2-hydroxy-lR-methylethyl)-5Z,8Z,11Z,14Z-eikosatetraenamid | ||
| Methedron | bk-PMMA | 1-(4-methoxyfenyl)-2-(methylamino)propan-1-on | |
| Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
| Methoxetamin | MXE | 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon | |
| methoxfenidin | MXP | 1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin | 2-MeO-difenidin |
| Methoxpropamin | MXPr, 2-Oxo-3'-methoxy-PCPr | 2-(3-methoxyfenyl)-2-(propylamino)cyklohexan-1-on | |
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| Methylklonazepam | ID 690; ID-690; methylclonazepam; Ro 05-4082; Ro 5-4082 | 5-(2-chlorfenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-on | |
| Methylon | Bk-MDMA | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | |
| Methyltenamfetamin | MDMA | (2R,S)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylthienylpropamin | MPA | N-methyl-1-(thiofen-2-yl)propan-2-amin | |
| Metizolam | Desmethyletizolam | 4-(2-chlorfenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Mexedron | 4-MMC-oMe; MEX | (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on | |
| m-Chlorfenylpiperazin | mCPP | 1-(3-chlorfenyl)piperazin | |
| M-CHMIC | 1-(cyklohexylmethyl)-2-methyl-indol-3-karboxylát | ||
| MN-18 | N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid | ||
| MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyklohexylmethyl)-1H-indazol-3-karboxylát | ||
| MPhP-2201 | methyl 2-{[1-(5-fluorpentyl)-1H-indol-3-yl]formamido}-3-fenylpropanoát | ||
| N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin | |||
| N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin | |||
| Naftylpyrovaleron | Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | O-2482 |
| N-butylhexedron | N-butylnorhexedrone, NBH | 2-(butylamino)-1-fenylhexan-1-on | |
| N-butylpentylon | butyl-pentylone, methylenedioxy-butylvalerophenone, MDBVP | 1-(1,3-benzodioxol-5-yl)-2-(butylamino)pentan-1-on | |
| NEB-inden analog | bk-IBP; , bk-EABDI | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-on | |
| N-ethylbufedron | NEB | 2-(ethylamino)-1-fenylbutan-1-on | |
| N-ethylheptedron | Ethylheptedrone | 2-(ethylamino)-1-fenyl-heptan-1-on | |
| N-ethylhexedron | HEX-EN; Ethylhexedrone; Ethyl-Hex | 2-(ethylamino)-1-fenyl-hexan-1-on | |
| N-ethyl-isohexedron | NEiH | 2-(ethylamino)-4-methyl-1-fenylpentan-1-on | |
| N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofenon |
| Nifoxipam | 5-(2-fluorfenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-on | ||
| N-isopropylhexedron | NiPH; N-isopropylhexedron | 2-(isopropylamino)-1-fenylhexan-1-on | |
| N-isopropylpentedron | NiPP; NPP, 2-IPP | 2-(isopropylamino)-1-fenylpentan-1-on | |
| Nitrazolam | 1-methyl-8-nitro-6-fenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | ||
| NM-2201, CBL-2201 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát | ||
| N-methyl-2-aminoindan | N-methyl-2AI | 2,3-dihydro-N-methyl-1H-inden-2-amin | NM-2AI |
| N-methylbenzedron | 2-[benzyl(methyl)amino]-1-(4-methylfenyl)propan-1-on | ||
| Norfludiazepam | N-desalkylflurazepam, desalkyl-flurazepam, norflurazepam, Ro 5-3367 | 7-chlor-5-(2-fluorfenyl)-1,3-dihydro-1,4-benzodiazepin-2-on | |
| N-propylnorpentedron | N-propylpentedron | 1-fenyl-2-(propylamino)pentan-1-on | |
| o-Acetylpsilocin | 4-AcO-DMT | {3-[2-(dimethylamino)ethyl]-1H-indol-4-yl }acetát | Psilacetin |
| o-Desmethyltramadol | ODT | 3-{-2-[(dimethylamino)methyl]-1-hydroxycyklohexyl}fenol | |
| Org 27569 | 5-chlor-3-ethyl-N-{2-[4-(1-piperidinyl)fenyl]ethyl}-1H-indol-2-karboxamid | ||
| Org 27759 | 5-fluor-3-ethyl-N-{2-[4-(dimethylamino)fenyl]ethyl}-1H-indol-2-karboxamid | ||
| Org 29647 | 5-chlor-3-ethyl-N-(1-benzylpyrrolidin-3-yl)-3H-indol-2-karboxamid | ||
| Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | ||
| PB-22 indazol analog | chinolin-8-yl-1-pentyl-1H-indazol-3-karboxylát | ||
| Pentedron | 1-fenyl-2-(methylamino)pentan-1-on | ||
| Pentylon | Methylendioxypentedron; βk-MBDP | (±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-on | |
| p-Fluorfenylpiperazin | pFPP | 1-(4-fluorfenyl)piperazin | |
| p-Methyl-4-methylaminorex | 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | p4-DMAR |
| Pravadolin | WIN 48,098 | (4-methoxyfenyl)-[2-methyl-1-(2-morfolin-4-ylethyl)indol-3-yl]methanon | |
| Propylkathinon | N-propylcathinone; PC | 1-fenyl-2-(propylamino)propan-1-on | |
| Propylon | N-propylnormethylone; bk-3,4-MDPA | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-on | |
| Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogenfosfát | ||
| PV8, α-PHPP | 1 -fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on | ||
| PV9, α-POP | 1 -fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | ||
| Pyrazolam | 8-brom-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3 -a] [1,4]benzodiazepin | ||
| RCS-4 | (4-methoxyfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| RCS-4 ortho izomer | (2-methoxyfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| RCS-4(C4) | 4-methoxyfenyl-(1-butyl-1H-indol-3-yl)methanon | ||
| Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexyl)pyrrolidin | |
| Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f] isochromen-7-karboxylát | ||
| SDB-005 | naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylát | ||
| SDB-006 | N-benzyl-1-pentyl-1H-indol-3-karboxamid | ||
| SDB-006 N-fenyl analog | 1-pentyl-N-fenyl-1H-indol-3-karboxamid | ||
| STS-135 | N-(1-adamantyl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Tenocyklidin | TCP | 1-[1-(2-thienyl)cyklohexyl]piperidin | |
| Tertylon | tBuONE; MDPT | 1-(1,3-benzodioxol-5-yl)-2-(tert-butylamino)propan-1-on | |
| Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
| Thionordazepam | 7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-thion | ||
| THJ-2201 | 5F-JWH-018-N, 5F-THJ-018, AM-2201 indazol analog | [1-(5-fluorpentyl)-1H-indazol-3-yl] (1 -nařryl)methanon | |
| TH-PBP; 3',4'-tetramethylene-α-PBP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronatalen-2-yl)butan-1-on | ||
| TH-PHP; 2-pyrrohdin-1-yl-1-tetralin-6-yl- hexan-1-on | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)hexan-1-on | ||
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | ||
| trans-CP 47,497-C8 | 5-(1,1-dimethyloktyl)-2-[(1S,3S)-3-hydroxycyklohexyl]-fenol | ||
| Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
| Trimethoxyamfetamin-2 | TMA-2 | (2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
| UR-144(-2H); XLR11 N-(4-pentenyl) derivát | [1-(pent-4-en-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | ||
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 | |
| UR-144 heptyl derivát | (1-heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)-methanon | ||
| UR-144 N-(5-chlorpentyl) derivát | (1-(5-chlorpentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| URB-597 | [3-(3-karbamoylfenyl)fenyl]-N-cyklohexylkarbamát | ||
| URB-754 | 6-methyl-2-[(4-methylfenyl)amino]-1-benzoxazin-4-on | ||
| W-15 | 4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid | ||
| W-18 | 4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid | ||
| WIN 55212-2 | (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morfolinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]naftalen-1-ylmethanon | ||
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | ||
| α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
| α-Pyrrolidinoisohexanofenon | α-ΡiΗΡ | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| α-Piperidinbutiofenon | α-PipBP | 1-fenyl-2-(piperidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiofenon | α-PBP | 1-fenyl-2-(pyrrolidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiothiofenon | α-PBT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)butan-1-on | |
| α-Pyrrolidinnonafenon | α-PNP; PV-10; alpha-pyrrolidi-nononaphenone | 1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on | |
| α-Pyrrolidinpropiofenon | α-PPP | 1-fenyl-2-(pyrrolidin-1-yl)propan-1-on | |
| β-Keto-indanylmethylaminopropan | bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on |
Including stereoisomers of psychotropic substances, except for the express exceptions listed in this list, in all cases where such stereoisomers may exist according to a specific chemical designation, and salts and esters of psychotropic substances listed in this list in all cases where they may exist.
Příloha č. 5
Annex No 5 to Government Regulation No 463 / 2013 Coll.
List No 5 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Amfetamin | (2RS)-1-fenylpropan-2-amin | ||
| Amineptin | kyselina 7-[(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)amino]heptanová | ||
| Buprenorfin | (2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethanomorfinan-7α-yl]-3,3 -dimethylbutan-2-ol | ||
| Bromdimethoxyfenethylamin | 2C-B | (4-brom-2,5-dimethoxyfenethyl)amin | |
| Dexamfetamin | (2S)-1-fenylpropan-2-amin | ||
| Fencyklidin | PCP | 1-(1-fenylcyklohexyl)piperidin | |
| Fenetylin | 7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H-purin-2,6-dion | ||
| Fenmetrazin | 2-fenyl-3-methylmorfolin | ||
| Fentermin | 1-fenyl-2-methylpropan-2-amin | ||
| Flunitrazepam | 5-(2-fluorfenyl)-1-methyl-7-nitro-1H-1,4-benzodiazepin-2(3H)-on | ||
| GHB | kyselina 4-hydroxybutanová | ||
| Levamfetamin | (2R)-1-fenylpropan-2-amin | ||
| Levmetamfetamin | (2R)-1-fenyl-N-methylpropan-2-amin | ||
| Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
| Meklochalon | 3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on | ||
| Metachalon | 2-methyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on | ||
| Metamfetamin | (2S)-1-fenyl-N-methylpropan-2-amin | ||
| Metamfetamin racemický | (2RS)-1-fenyl-N-methylpropan-2-amin | ||
| Methylfenidát | methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát | ||
| Psilocybin pro léčebné použití | [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen- fosfát | Léčivá látka podle zákona č. 378/2007 Sb., o léčivech a o změnách některých souvisejících zákonů (zákon o léčivech). | |
| Sekobarbital | kyselina 5-allyl-5-(1-methylbutyl)barbiturová | ||
| Dronabinol | delta-9-THC | Δ9-tetrahydrokanabinol (THC) a jeho stereoizomery a estery | např. (-)-trans-Δ9-THC |
| Zipeprol | (2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl]propan-2-ol |
Including salts of substances listed in this group in all cases where the existence of such salts is possible.
Příloha č. 6
Annex No 6 to Government Regulation No 463 / 2013 Coll.
List No 6 psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Amobarbital | kyselina 5-ethyl-5-isopentylbarbiturová | ||
| Butalbital | kyselina 5-allyl-5-isobutylbarbiturová | ||
| Cyklobarbital | kyselina 5-(1-cyklohex-1-en-1-yl)-5-ethylbarbiturová | ||
| Gamabutyrolakton | GBL | oxolan-2-on | S výjimkou přípravků s obsahem GBL, z nichž nelze získat GBL ekonomicky přijatelným způsobem a jejichž perorální nebo jiné podání je vyloučené z důvodů zdravotních či chuťových. |
| Glutethimid | (3RS)-3-ethyl-3-fenylpiperidin-2,6-dion | ||
| Kathin | (+)-norpseudoefedrin | (1S,2S)-2-amino-1-fenylpropan-1-ol | |
| Pentazocin | (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | ||
| Pentobarbital | kyselina 5-ethyl-5-[(1RS)-1-methylbutyl]barbiturová |
Including salts of substances listed in this group in all cases where the existence of such salts is possible.
Příloha č. 7
Annex No 7 to Government Regulation No 463 / 2013 Coll.
List No 7 psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Allobarbital | 5,5-diallylbarbiturová kyselina | ||
| Alprazolam | 8-chlor-6-fenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Amfepramon | 2-(diethylamino)-1-fenylpropan-1-on | ||
| Aminorex | 5-fenyl-4,5-dihydrooxazol-2-amin | ||
| Barbital | 5,5-diethylbarbiturová kyselina | ||
| Bentazepam | CI 718; QM 6008; Thiadipone; | 5-fenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e] [1,4]diazepin-2-on | |
| Benzfetamin | (+)-N-benzyl-N-(2-fenyl-1-methylethyl)-N-methylamin | ||
| Benzylpiperazin | 1-benzylpiperazin | ||
| Bromazepam | 7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Brotizolam | 2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin | ||
| Butobarbital | 5-butyl-5-ethylbarbiturová kyselina | ||
| Cinazepam | BD-798; | 4-[[7-brom-5-(2-chlorfenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanová kyselina | |
| Delorazepam | 7-chlor-5-(2-chlorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Diazepam | 7-chlor-5-fenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Estazolam | 8-chlor-6-fenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Ethinamát | N-(1-ethynylcyklohexyl)karbamát | ||
| Ethchlorvynol | 1-chlor-3-ethylpent-1-en-4-yn-3-ol | ||
| Ethylamfetamin | (±)-2-(ethylamino)-1-fenylpropan | ||
| Ethylloflazepát | ethyl-7-chlor-5-(2-fluorfenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-karboxylát | ||
| Fenazepam | 7-Bromo-5-(2-chlorofenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Fendimetrazin | (2S,3S)-2-fenyl-3,4-dimethylmorfolin | ||
| Fenkamfamin | (±)-2-(ethylamino)-3-fenylbicyklo[2.2.1]heptan | ||
| Fenobarbital | 5-ethyl-5-fenylbarbiturová kyselina | ||
| Fenproporex | (±)-1-fenyl-2-[(2-kyanethyl)amino] propan | ||
| Fludiazepam | 7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Flurazepam | 7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Halazepam | 7-chlor-5-fenyl-1-(2,2,2-trifluorethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| HN-oxazolam | 10-brom-11b-(2-fluorfenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-on | ||
| Chlordiazepoxid | 7-chlor-5-fenyl-2-(methylamino)-3H-1,4-benzodiazepin-4-oxid | ||
| Kamazepam | 7-chlor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethylkarbamát | ||
| Karisoprodol | (RS)-2-{[(aminokarbonyl)oxy]methyl}-2-methylpentyl isopropylkarbamát | ||
| Ketamin | (2RS)-2-(2-chlorfenyl)-2-(methylamino)cyklohexan-1-on | ||
| Ketazolam | 11-chlor-12b-fenyl-2,8-dimethyl-8,12b-dihydro-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dion | ||
| Klobazam | 7-chlor-5-fenyl-1-methyl-1H-1,5-benzodiazepin-2,4(3H,5H)-dion | ||
| Klonazepam | 5-(2-chlorfenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Klorazepát | 7-chlor-5-fenyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-karboxylová kyselina | ||
| Klotiazepam | 5-(2-chlorfenyl)-7-ethyl-1-methyl-1,3-dihydro-2H-thieno[2,3-e][1,4]diazepin-2-on | ||
| Kloxazolam | 10-chlor-11b-(2-chlorfenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-on | ||
| Lefetamin | SPA | (-)-1-(dimethylamino)-1,2-difenylethan | |
| Loprazolam | 6-(2-chlorfenyl)-2-[(4-methylpiperazin-1-yl)methyl]-8-nitro-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-on | ||
| Lorazepam | 7-chlor-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Lormetazepam | 7-chlor-5-(2-chlorfenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Mazindol | 5-(4-chlorfenyl)-2,5-dihydro-3H-imidazo[2.1-α]-isoindol-5-ol | ||
| Medazepam | 7-chlor-5-fenyl-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin | ||
| Mefenorex | (±)-2-[(3-chlorpropyl)amino]-1-fenylpropan | ||
| Meprobamát | 2-methyl-2-propylpropan-1,3-diyl-dikarbamát | ||
| Mesokarb | N-(fenylkarbamoyl)-3-(2-fenyl-1-methylethyl)sydnonimin | ||
| Methylfenobarbital | 5-ethyl-5-fenyl-1-methylbarbiturová kyselina | ||
| Methyprylon | 3,3-diethyl-5-methylpiperidin-2,4-dion | ||
| Midazolam | 8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin | ||
| Nimetazepam | 5-fenyl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nitrazepam | 5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nordazepam | 7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazepam | 7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazolam | 10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-on | ||
| Pemolin | 5-fenyl-2-imino-1,3-oxazolidin-4-on | ||
| Pinazepam | 7-chlor-5-fenyl-1-(prop-2-yn-1-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Pipradrol | difenyl(2-piperidyl)methanol | ||
| Prazepam | 7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Pyrovaleron | (±)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | ||
| Sekbutabarbital | 5-ethyl-5-(1-methylpropyl)barbiturová kyselina | ||
| Temazepam | (RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Tetrazepam | 7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Tofisopam | Grandaxin, Emandaxin, EGYT 341 Nodeprine, Seriel, TF | 1-(3,4-dimethoxyfenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepin | |
| Triazolam | 8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Vinylbital | 5-(1-methylbutyl)-5-vinylbarbiturová kyselina | ||
| Zolpidem | N,N,6-trimethyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-acetamid |
Including salts of psychotropic substances listed in this list in all cases where such salts may exist.
Příloha č. 8
Annex No 8 to Government Regulation No 463 / 2013 Coll.
List No 8 selected products
| Přípravky obsahující: | Podmínky: |
|---|---|
| 1) jednu z omamných látek: acetyldihydrokodein dihydrokodein ethylmorfin folkodin kodein nikodikodin nikokodin norkodein | Mohou obsahovat jednu nebo více dalších látek (nikoliv však omamných) a množství omamné látky a) v jedné tabletě, tobolce, ampuli, čípku, příp. v jiné lékové formě nesmí přesáhnout 100 mg, b) v roztoku nesmí být koncentrace vyšší než 2,5 %. |
| 2) difenoxin | a) Množství difenoxinu nesmí přesáhnout v jedné tabletě, tobolce, ampuli, čípku, příp. v jiné lékové formě 0,5 mg. b) Množství atropin-sulfátu musí být nejméně 5 % k množství difenoxinu v jedné tabletě, kapsli, ampuli, čípku, popř. jiné lékové formě. |
| 3) difenoxylát | a) Množství difenoxylátu nesmí přesáhnout v jedné tabletě, tobolce, ampuli, čípku, příp. v jiné lékové formě 2,5 mg. b) Množství atropin-sulfátu musí být nejméně 1 % k množství difenoxylátu v jedné tabletě, tobolce, ampuli, čípku, popř. v jiné lékové formě. |
| 4) dextropropoxyfen | Množství dextropropoxyfenu a) nesmí přesáhnout 135 mg v jedné tabletě, tobolce, ampuli, čípku, příp. v jiné lékové formě, b) v roztoku nesmí být koncentrace vyšší než 2,5 %. Přípravek nesmí obsahovat žádnou psychotropní látku. |
| 5) kokain | Množství kokainu nesmí přesáhnout 0,1 % kokainu. |
| 6) opium nebo morfin | a) Množství morfinu nesmí přesáhnout 0,2 %. b) Dále mohou obsahovat jednu nebo více dalších látek (nikoliv však omamných). Omamná látka v přípravku obsažená nesmí být snadno získána zpět v takovém množství, aby ohrozila veřejné zdraví. |
| 7) ipekakuanhový prášek s opiem | a) Množství opia v prášku nesmí být vyšší než 10%. b) Množství ipekakuanhového kořene nesmí být vyšší než 10 %. c) Množství jedné nebo více dalších látek (nikoliv však omamných) nesmí být nižší než 80 %. |
| 8) propiram | a) Množství propiramu nesmí přesáhnout 100 mg v jedné tabletě, tobolce, ampuli, čípku, příp. v jiné lékové formě. b) Množství methylcelulosy v přípravku musí být nejméně stejné nebo vyšší než propiramu. |
Including homeopathic products with a dilution rate greater than D4 or CH2.
1) Single Convention on Narcotic Drugs, published under No 47 / 1965 Coll., as amended by the Protocol on Amendments to the Single Convention on Narcotic Drugs, published under No 458 / 1991 Coll.
2) Convention on Psychotropic Substances, published under No 62 / 1989 Coll.
3) Council Framework Decision 2004 / 757 / JHA of 25 October 2004 laying down minimum provisions concerning the characteristics of the facts of offences and penalties in the field of illicit drug trafficking. Directive (EU) 2017 / 2103 of the European Parliament and of the Council of 15 November 2017 amending Council Framework Decision 2004 / 757 / JHA to include new psychoactive substances in the definition of drugs and repealing Council Decision 2005 / 387 / JHA. Commission Delegated Directive (EU) 2019 / 369 of 13 December 2018 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of new psychoactive substances in the definition of drugs. Commission Delegated Directive (EU) 2020 / 1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of the new psychoactive substance N, N-diethyl-2- [4- (1-methylethoxy) phenyl] methyl] -5-nitro-1H-benzimidazol-1-ethanamine (isotonitazene) in the definition of drug. Commission Delegated Directive (EU) 2021 / 802 of 12 March 2021 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of new psychoactive substances methyl 3,3-dimethyl-2- {[1- (pent-4-en-1yl) -1H-indazol-3-carbonyl] amino} butanoate (MDMB-4en-PINACA) and methyl 2- {[1- (4-fluorobutyl) -1H-indol-3-carbonyl] amino} -3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of drugs. Commission Delegated Directive (EU) 2022 / 1326 of 18 March 2022 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of new psychoactive substances in the definition of drugs.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No. 463 / 2013 Coll., on substance lists |
|---|---|
| Regulation Type | Regulation |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 31.12.2013 |
|---|---|
| Effective from | 01.01.2014 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0